When AFP and DCP were combined with MC, the hazard ratio of HCC recurrence risk increased from 2.6 for patients beyond MC to 8.6 when AFP serum levels were ≥250 ng/mL and to 7.2 when DCP serum levels were ≥7.5 ng/mL. Here, ACE is linked to hepatocellular carcinoma.